Assembly Biosciences, Inc.
ASMB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $10,789 | $9,626 | $9,419 | $7,357 |
| % Growth | 12.1% | 2.2% | 28% | – |
| Cost of Goods Sold | $0 | $16,125 | $0 | $14,280 |
| Gross Profit | $10,789 | -$6,499 | $9,419 | -$6,923 |
| % Margin | 100% | -67.5% | 100% | -94.1% |
| R&D Expenses | $16,587 | $16,125 | $14,851 | $14,280 |
| G&A Expenses | $5,085 | $4,594 | $4,509 | $4,609 |
| SG&A Expenses | $5,085 | $4,594 | $4,509 | $4,609 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$16,125 | $0 | -$14,280 |
| Operating Expenses | $21,672 | $4,594 | $19,360 | $4,609 |
| Operating Income | -$10,883 | -$11,093 | -$9,941 | -$11,532 |
| % Margin | -100.9% | -115.2% | -105.5% | -156.7% |
| Other Income/Exp. Net | $1,687 | $895 | $1,123 | $1,273 |
| Pre-Tax Income | -$9,196 | -$10,198 | -$8,818 | -$10,259 |
| Tax Expense | $0 | $0 | $0 | $76 |
| Net Income | -$9,196 | -$10,198 | -$8,818 | -$10,335 |
| % Margin | -85.2% | -105.9% | -93.6% | -140.5% |
| EPS | -1.2 | -1.33 | -1.17 | -1.72 |
| % Growth | 9.8% | -13.7% | 32% | – |
| EPS Diluted | -1.2 | -1.33 | -1.17 | -1.72 |
| Weighted Avg Shares Out | 7,656 | 7,656 | 7,506 | 6,581 |
| Weighted Avg Shares Out Dil | 7,656 | 7,656 | 7,506 | 6,581 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,687 | $895 | $1,123 | $1,121 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $32 | $32 | $33 | $32 |
| EBITDA | -$9,164 | -$11,061 | -$9,908 | -$11,500 |
| % Margin | -84.9% | -114.9% | -105.2% | -156.3% |